Sign In

Thomas Chalberg

Entrepreneur, Executive, Investor

Dr. Thomas W. Chalberg, PhD, is a renowned scientist, entrepreneur, and executive based in Silicon Valley, with a strong focus on oncology and ophthalmology.

As the founder and former CEO of Avalanche Biotechnologies, now Adverum Biotechnologies, Dr. Chalberg led the company through a highly successful initial public offering in 2014, making it a key player in gene therapies for blinding diseases.

With over 15 years of experience in developing innovative therapies for vision enhancement and eye health, Dr. Chalberg has been lauded for his groundbreaking contributions to research and development.

His educational background includes a BA in Biochemical Sciences from Harvard University, a PhD in Genetics from Stanford University School of Medicine, and an MBA from the UC Berkeley Haas School of Business, providing him with a unique blend of scientific and business expertise.

Dr. Chalberg's skills and expertise span areas such as entrepreneurship, drug development, gene therapy, ophthalmology, and commercialization, making him a well-rounded leader in the biotechnology field.

He has held key roles in organizations like SightGlass Vision, Oncorus, and Genentech, showcasing his versatile experience and leadership in both startup ventures and established companies.

Recognized as a Technology Pioneer by the World Economic Forum and honored for breakthrough deals in the industry, Dr. Chalberg continues to drive innovations that have a profound impact on healthcare and biotechnology.

Thomas Chalberg
Add to my network

Location

Palo Alto, California, United States